Predict your next investment

HEALTHCARE | Biotechnology
situgen.com

See what CB Insights has to offer

Stage

Private Equity | Alive

Total Raised

$1M

Last Raised

$1M | 15 yrs ago

About SituGen

Developer of technologies dealing with the use of umbilical cord blood (UCB).

SituGen Headquarter Location

27 Habarzel Street

Tel Aviv, 61650,

Israel

972 3 7684945

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

SituGen Patents

SituGen has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/11/2006

6/28/2016

Stem cells, Developmental biology, Embryology, Midwifery, Obstetrics

Grant

Application Date

9/11/2006

Grant Date

6/28/2016

Title

Related Topics

Stem cells, Developmental biology, Embryology, Midwifery, Obstetrics

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.